Closed consultation NICE Equality Consultation - Clinical Guideline NG242 - Diabetic retinopathy: management and monitoring

Summary

NICE guidance is designed and developed for the NHS in England and is therefore not automatically applicable to Northern Ireland. Guidance is locally reviewed for applicability to Northern Ireland and, where appropriate, is endorsed for implementation in health and social care. THE LOCAL REVIEW DOES NOT REASSESS THE CLINICAL AND COST EVIDENCE USED BY NICE IN FORMING ITS ADVICE. The Department’s link with NICE has ensured that Northern Ireland has access to up-to-date, independent, professional, evidence-based guidance on the value of health care interventions.

Documents

• Equality Questionnaire - NICE Clinical Guideline NG242 Microsoft Word (14 KB)
• Equality-Questionnaire-NICE Clinical Guideline NG242 Adobe PDF (11 KB)

Help viewing documents

Consultation description

Guidance for the consultation can be found on the NICE Website.

The HSC (SQSD) 13/22 circular provides details of the process for the endorsement, implementation, monitoring and assurance of NICE Clinical Guidelines in Northern Ireland

In order to meet the timescales set out in the circular, the closing date for responses is 23 September 2024.

Ways to respond

Consultation closed — responses are no longer being accepted.